A Phase 1/2a study of TP-122A in Ventilator-Associated Pneumonia
Not Yet Recruiting Phase 1,Phase 2 NCT06370598
Study Description
A study to evaluate the safety and effectiveness of TP-122A, a bacteriophage cocktail, in treating Ventilator-Associated Pneumonia caused by Pseudomonas aeruginosa
Study Details
- Registry ID:
- NCT06370598
- Conditions:
- Pneumonia, Ventilator-Associated
- Phase:
- Phase 1,Phase 2
- Target Enrollment:
- 15 participants
- Start Date:
- Age Range:
- 18–99 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
CH Nantes
Nantes, France
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.